Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan

NAV
₹9.5538
+0.04%
(3 Oct)
AUM
637 Cr
TER
0.43%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
-1.0%
-1.3%
-1.3%
-1.3%
NA
3Y
+34.2%
+34.7%
+34.7%
+34.7%
NA
5Y
+31.8%
+34.0%
+34.0%
+34.0%
NA
ALL
+16.7%
+12.1%
+12.1%
+12.1%
-4.5%
VOL
20.2%
20.2%
20.2%
20.2%
10.2%
TER
0.9%
0.8%
0.8%
0.8%
0.4%
AUM
₹1,341 Cr
₹5,179 Cr
₹5,179 Cr
₹5,179 Cr
₹637 Cr
INFO
0.83
0.60
0.60
0.60
-0.44
See fund holdings as of 31st Aug
Top holdings
Sun Pharmaceuticals Industries Ltd
12.5%
Divi's Laboratories Ltd
7.2%
Clearing Corporation Of India Ltd
6.1%
Apollo Hospitals Enterprise Ltd
6.0%
Mankind Pharma Ltd
5.8%
Cipla Ltd
5.5%
Max Healthcare Institute Ltd Ordinary Shares
4.9%
Aster DM Healthcare Ltd Ordinary Shares
3.6%
Abbott India Ltd
3.5%
Torrent Pharmaceuticals Ltd
3.3%
Top industry exposure
Healthcare
91.4%
Financial Services
2.7%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
5%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs